Center-Authored Papers

Filters: Author is Smith, David C  [Clear All Filters]
2009
deVere White RW, Lara PN, Goldman B, Tangen CM, Smith DC, Wood DP, Hussain MHA, Crawford DE.  2009.  A sequential treatment approach to myoinvasive urothelial cancer: a phase II Southwest Oncology Group trial (S0219).. The Journal of urology. 181(6):2476-80;discussion2480-1. Abstract
2014
Basch EM, Autio KA, Smith MR, Bennett AV, Weitzman AL, Scheffold C, Sweeney C, Rathkopf DE, Smith DC, George DJ et al..  2014.  Effects of Cabozantinib on Pain and Narcotic Use in Patients with Castration-resistant Prostate Cancer: Results from a Phase 2 Nonrandomized Expansion Cohort.. European urology. Abstract
Hussain M, Daignault S, Agarwal N, Grivas PD, Siefker-Radtke AO, Puzanov I, Macvicar GR, Levine EG, Srinivas S, Twardowski P et al..  2014.  A randomized phase 2 trial of gemcitabine/cisplatin with or without cetuximab in patients with advanced urothelial carcinoma.. Cancer. Abstract
2015
Jones RL, Bendell JC, Smith DC, Diefenbach K, Lettieri J, Boix O, Lockhart CA, O'Bryant C, Moore KN.  2015.  A phase I open-label trial evaluating the cardiovascular safety of regorafenib in patients with advanced cancer.. Cancer chemotherapy and pharmacology. Abstract
Smith DC, Kalebic T, Infante JR, Siu LL, Sullivan D, Vlahovic G, Kauh JS, Gao F, Berger AJ, Tirrell S et al..  2015.  Phase 1 study of ixazomib, an investigational proteasome inhibitor, in advanced non-hematologic malignancies.. Investigational new drugs. 33(3):652-63. Abstract
Robinson D, Van Allen EM, Wu Y-M, Schultz N, Lonigro RJ, Mosquera J-M, Montgomery B, Taplin M-E, Pritchard CC, Attard G et al..  2015.  Integrative clinical genomics of advanced prostate cancer.. Cell. 161(5):1215-28. Abstract
2016
Chow LQM, Smith DC, Tan AR, Denlinger CS, Wang D, Shepard DR, Chaudhary A, Lin Y, Gao L.  2016.  Lack of pharmacokinetic drug-drug interaction between ramucirumab and paclitaxel in a phase II study of patients with advanced malignant solid tumors.. Cancer chemotherapy and pharmacology. 78(2):433-41. Abstract
Olszanski AJ, Smith DC, Camacho LH, Thompson J, Ramalingam SS, Harvey DR, Campos L, Ferry D, Tang S, Gao L et al..  2016.  Electrocardiographic Characterization of Ramucirumab on the Corrected QT Interval in a Phase II Study of Patients With Advanced Solid Tumors.. The oncologist. Abstract
2017
Frankel AE, Flaherty KT, Weiner GJ, Chen R, Azad NS, Pishvaian MJ, Thompson JA, Taylor MH, Mahadevan D, Lockhart CA et al..  2017.  Academic Cancer Center Phase I Program Development.. The oncologist. Abstract